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Background: Humans are exposed to an array of both harmful and beneficial hormonally active compounds in the
environment and through diet. Two such chemicals are Bisphenol A (BPA), a plasticizer, and genistein, a component
of soy. Prepubertal exposure to BPA increased mammary carcinogenesis, while genistein suppressed cancer in a
chemically-induced model of rodent mammary cancer. The purpose of this research was to determine the effects of
combinational exposure to genistein and BPA on cell proliferation, apoptosis, and associated proteins as markers of
cancer in mammary glands of rats exposed prepubertally to these environmental chemicals.
Methods: Prepubertal rats (postpartum days (PND) 2–20) were exposed through lactation via nursing dams treated
orally with sesame oil (SO), BPA, genistein, or a combination of BPA and genistein (BPA + Gen). Cell proliferation,
apoptosis and protein expressions were investigated for mechanistic studies in mammary glands of rats exposed to
these environmental chemicals.
Results: Prepubertal exposure to genistein increased cell proliferation in mammary glands of PND21 rats, while BPA
increased cell proliferation in adult (PND50) rats. Prepubertal combinational exposure to BPA + Gen increased cell
proliferation and reduced apoptosis in PND21 rats, but reduced cell proliferation and increased apoptosis in PND50
rats. The altered mechanisms behind these cellular responses appear to be centered on differential protein expression
of caspases, PARP, Bad, p21, Akts, PTEN, ER-β and SRCs 1–3, in the rat mammary gland.
Conclusion: Prepubertal BPA exposure resulted in increased cell proliferation in mammary glands of PND50 rats, a
process associated with increased risk of cancer development in a chemically-induced mammary cancer. On the other
hand, genistein stimulated cell proliferation at PND21, a process that correlates with mammary gland maturation and
chemoprevention. In contrast to single chemical exposure, combinational exposure to BPA + Gen performed
most similarly to genistein exposure alone. BPA + Gen increased cell proliferation at PND21, suggesting mammary gland
maturation, and decreased cell proliferation while increasing apoptosis in PND50 rats, suggesting mammary
chemoprevention. Differential expression of proteins involved in regulating cell proliferation and apoptosis
lend support to these chemicals, both alone and in combination, altering mammary gland cancer susceptibility.
Keywords: Bisphenol A, Genistein, Proliferation, Apoptosis, Mammary cancer* Correspondence: feijun@uab.edu
1Department of Pharmacology and Toxicology, University of Alabama at
Birmingham, Birmingham, AL 35294, USA
Full list of author information is available at the end of the article
© 2014 Wang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Table 1 A list of animal treatment
Group identification Gavage administered Food administered
1). Control (SO) Sesame Oil as Vehicle AIN-76A
2). Bisphenol A (BPA) 250 ug BPA/kg BW AIN-76A
3). Genistein (Gen) Sesame Oil as Vehicle 250 mg Genistein/kg
AIN-76A diet
4). BPA + Genistein
(BPA + Gen)
250 ug BPA/kg BW 250 mg Genistein/kg
AIN-76A diet
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Epidemiological studies suggest that exposure to envir-
onmental estrogens affects cancer rates [1]. However,
the exact effects of environmental estrogens on the biol-
ogy of the mammary gland remain elusive. Such is the
case of the plasticizer, BPA, and the isoflavone, genistein.
BPA is one of the highest volume chemicals produced
worldwide, with an estimated 7% annual growth due
to manufacturing demand. It is used as a monomer to
manufacture polycarbonate plastics, epoxy resins that
line most food and beverage cans, and dental sealants.
Time, heat, and acidic or basic conditions accelerate hy-
drolysis of the ester bond linking BPA monomers, lead-
ing to the release of BPA into food and liquid and
making human environmental exposure inevitable and
ubiquitous [2]. In the United States, recent measure-
ments by the Center for Disease Control revealed detect-
able levels of BPA in random spot collected urine
samples from 92.6% of more than 2500 participants
in the cross-sectional National Health and Nutrition
Examination Survey study [3]. Further, BPA has been
detected in amniotic fluid, maternal and fetal plasma,
placental tissue of pregnant women, and in breast milk
of lactating mothers [4,5].
Genistein is a phytoestrogen found in many food prod-
ucts, especially soy-based foods such as tofu, soymilk,
soy infant formula and in some over-the-counter dietary
supplements. Dietary exposure to genistein can reach up
to 1 mg/kg body weight (BW) in adults and up to
10-fold higher levels in infants fed milk formulas contain-
ing soy [6]. The level of genistein exposure in Asian pop-
ulations consuming a soy-rich diet has been reported to
range from ~1 to 30 mg/d, or ~0.02–0.55 mg/kg BW× d,
and considerably less in Western populations [7]. Oral
exposure to genistein during the early prepubertal period
decreased susceptibility of the mammary gland to carcino-
genesis [8-10], whereas exposure during the same period
of time to BPA increased susceptibility to chemically-
induced mammary cancer [9,11,12]. Although both BPA
and genistein possess weak estrogenic properties, these
chemicals appear to influence the mammary gland via un-
known, yet different, mechanisms.
To better understand the mechanisms of BPA and ge-
nistein exposure, both alone and in combination, we
investigated the effects of prepubertal BPA and/or genis-
tein exposure on cell proliferation and apoptosis in the
structures most susceptible to mammary carcinogenesis,
the terminal end buds (TEBs). Further, we assessed the
expression of proteins in signalling pathways implicated
in mammary gland maturation, cell proliferation, and
apoptosis in the mammary glands of PND21 and PND50
rats. Differential cell proliferation, apoptosis, and protein
expression patterns in the mammary glands of rats pre-
pubertally exposed to BPA and genistein, both alone andin combination, suggest mechanisms for the altered sus-




Animal care and treatments were performed according
to established guidelines, and protocols were approved
by the UAB Animal Care Committee. Seven week old fe-
male Sprague–Dawley rats were purchased from Charles
River Laboratories (Wilmington, MA). Animals were
housed in a temperature controlled facility with a 12-h
light:dark cycle. These animals were bred with proven
Sprague–Dawley studs in our facilities, fed phytoestrogen-
free AIN-76A diet (Harlan Teklad, Madison WS), housed
in polypropylene cages and water provided via glass bot-
tles (all polycarbonate/BPA free). On the day of birth
(designated as PND zero), offspring were sexed and lit-
ters were culled to 10 offspring per lactating dam. Be-
ginning on PND2 and continuing through PND20, the
lactating dams were treated as listed below (Table 1).
Genistein was provided by DSM Nutritional Products
(Basel, Switzerland). BPA, sesame oil, and all other che-
micals were from Sigma Chemical Co. (St. Louis, MO).
Offspring were weaned at PND21 and fed AIN-76A diet.
For biochemical studies, female offspring were killed on
PND21 and 50 (prepubertal and young adult rats, re-
spectively). At PND50, female offspring were killed in
the estrous phase. The fourth abdominal mammary
glands were rapidly dissected from live ketamine/xylazine
anesthetized animals (to minimize proteolysis), snap-
frozen in liquid nitrogen, and stored at −80ºC or placed
in 10% formalin for later analysis.
Immunohistochemistry
Immunohistochemistry (IHC) of tissue sections from
formalin fixed mammary glands was employed to meas-
ure Ki-67 antigen as a marker for proliferating cells in
mammary glands of PND21 and PND50 rats (n = 6 per
group). After being blocked in 2.5% normal horse serum,
sections were incubated with monoclonal mouse anti-rat
Ki-67 antigen (clone MIB-5 antibody, Dako Cytomation,
Carpinteria, CA), and diluted in PBS with 1% BSA for
30 min. Chromogen, diaminobenzidine (DAB) (Vector)
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tap water for 5 min. To counter-stain, hematoxylin QS
(Vector) was applied to the specimens for one min
followed by a wash in tap water. The slides were evalu-
ated using a Nikon Labophot-2 microscope (Nikon
Corporation, Tokyo, Japan), and data were digitally re-
corded using a Nikon 8.0 Mega Pixels CoolPix 8700 Digital
Camera (Nikon). The pictures were counted using Image J
software (Image J, NIH). The epithelial cells of TEBs posi-
tive for Ki-67 (stained brown) were counted as well as the
non-proliferative epithelial cells (stained blue). Approxi-
mately 800 epithelial cells per specimen were counted in
the TEBs of mammary glands. A TEB is characterized as
an elongated ductal structure with 3 to 6 epithelial cell
layers and >100 micrometers in diameter [13]. The prolif-
erative index was calculated by dividing the number of
positively stained cells by the total number of cells counted
and expressed as a percentage.
In situ apoptosis labelling
For apoptosis assessment, the TUNEL assay was per-
formed with ApopTag Plus Peroxidase In Situ Apoptosis
Detection kit (Chemicon International, Temecula, CA)
following the manufacturer’s instructions. For quantita-
tion of apoptotic cells, two parameters were used to
identify apoptotic cells. First, we used positive immune-
labelling as detected by ApopTag staining. Second, cells
that were positive by immune-labelling were then con-
firmed by morphological characteristics typical of cells
undergoing programmed cell death, i.e., including chro-
matin aggregation, nuclear, and cytoplasmic condensa-
tion as well as fragmentation of the dying cell into a
cluster of membrane bound segments. If a cell was
judged to be apoptotic by both criteria, it was judged
positive. At PND21 and PND50, cell apoptotic indices
were generated by counting over 1000 cells in the TEBs
in more than four separate microscopic fields showing
the highest density of immunostained cells per slide
under a microscope and expressed as the percentage of
positive cells per total number of TEB epithelial cells
counted (n = 6 per treatment).
Immunoblotting
To determine the changes in protein expression, six
mammary gland samples per treatment group were in-
vestigated by western blot analysis. The same quantity of
protein from each sample was separated by SDS-PAGE
and transferred to a nitrocellulose membrane (Bio-Rad,
Hercules, CA). The membranes were blocked and
immunoblotted with appropriate antibodies. Molecular
weight ladders (Bio- Rad) and reference proteins from
the respective companies were used as positive con-
trols. Nitrocellulose membranes were incubated with
an appropriate secondary antibody conjugated to HRP(Cell Signaling Technology), followed with a chemilu-
minescent substrate (Pierce) and exposed to X-ray radi-
ography film. Table 2 provides the identity, description,
commercial source, and conditions of the primary and
secondary antibodies used in immunoblotting. Quantitative
analysis of protein expression was accomplished by scan-
ning autoradiogram and densitometry (ImageJ, NIH).
Statistical analysis
Statistical analyses of morphometric and biochemical
analyses were performed by using one way analysis of
variance (ANOVA), with subsequent post-hoc compari-
sons using pre-planned linear contrast to determine sig-
nificance (P < 0.05).
Results
Vaginal opening, body weights, and organ weights
Beginning at 24 days postpartum, female offspring were
evaluated for day of vaginal opening, and body weight at
the day of vaginal opening. Average time to vaginal
opening was 33.8 ± 0.3, 33.7 ± 0.3, 33.5 ± 0.3, and 33.9 ±
0.4 days for SO (controls), genistein, BPA, and BPA +
Gen treatments, respectively (p = 0.09). Average weight
at time of vaginal opening was 118.7 ± 2.1, 114.1 ± 3.7,
110.8 ± 1.9, and 117.0 ± 2.6 grams for SO, genistein, BPA,
and BPA +Gen treatments, respectively (p = 0.24). Body
weights were assessed at PND7, 14, 21, 50, and 100 and
no significant differences were observed between any of
the treatment groups (data not shown). Uteri and ovaries
were dissected out and weighed on PND21, 50, and 100.
No significant changes were noted between any of the
groups (data not shown).
Cellular proliferation and apoptosis in the mammary
glands of PND21 rats
At PND21, rats exposed prepubertally to genistein exhib-
ited a significant increase in the cell proliferation index in
mammary gland TEBs (p < 0.01) as compared to controls
(SO) (Figure 1A). BPA +Gen combination treatment sig-
nificantly increased cell proliferation compared to control
as well as BPA only exposure (p < 0.001). In the analysis of
apoptosis, prepubertal BPA +Gen combination treatment
reduced apoptosis in the mammary glands of PND21 rats
as compared to control (p < 0.001) and BPA only exposure
(Figure 1B). Using the ratio of cell proliferation and apop-
tosis to estimate cell turnover in mammary TEBs, genistein
only exposure increased the ratio compared with controls
(p < 0.01) (Figure 1C), Likewise, BPA +Gen exposure re-
sulted in an increased cell proliferation to apoptosis ratio
in mammary TEBs of PND21 rats.
Protein expression in mammary glands of PND21 rats
To determine the mammary gland’s molecular response
to chemical exposure during the prepubertal period, we
Table 2 Primary and secondary antibodies for immunoblot analysis
Primary Antibodies
Antibody name Supplier Product number Source Dilution Molecular weights
Akt-1 Cell Signaling 2938 Rabbit 1:1000 60 kDa
Akt-2 Cell Signaling 5239 Mouse 1:1000 60 kDa
Akt-3 Cell Signaling 3788 Rabbit 1:1000 60 kDa
p-Akt Cell Signaling 4060 Rabbit 1:2000 60 kDa
Cleaved Caspase-3 Cell Signaling 9661 Rabbit 1:1000 17/19 kDa
Cleaved Caspase-9 Cell Signaling 9507 Rabbit 1:1000 17 kDa
PARP Cell Signaling 9542 Rabbit 1:1000 89/116 kDa
p-Bad Cell Signaling 9296 Mouse 1:1000 23 kDa
p21 Cell Signaling 2946 Mouse 1:1000 21 kDa
PTEN Cell Signaling 9552 Rabbit 1:1000 54 kDa
ER-α R&D System MAB57151 Mouse 1:2000 65 kDa
ER-β Santa Cruz sc-8974 Rabbit 1:200 56 kDa
SRC-1 BD Biosciences 612378 Mouse 1:250 165 kDa
SRC-2/TIF2 BD Biosciences 610984 Mouse 1:250 160 kDa
SRC-3/AIB-1 BD Biosciences 611105 Mouse 1:250 160 kDa
GAPDH Cell Signaling 2118 Rabbit 1:1000 38 kDa
Secondary Antibodies
Antibody Name Supplier Product Number Source Dilution
Anti-Rabbit IgG HRP R&D System HAF008 Goat 1:2000
Anti-Mouse IgG HRP R&D System HAF007 Goat 1:2000
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of signalling pathways linked to cell proliferation and
apoptosis in the mammary glands of PND21 rats. We
found that, as compared to control, prepubertal BPA
treatment significantly increased p21 protein expression
but had no effect on cleaved caspase-3 and p-Akt, while
genistein treatment resulted in decreased cleaved caspase-
3 and increased p-Akt protein expression (Figure 2).
Interestingly, combinational BPA +Gen treatment de-
creased cleaved caspase-3 and p21 compared to BPA
treatment alone and decreased p-Akt protein compared
to genistein treatment alone. Only the 19 kDa fragment
of cleaved caspase-3 was detected, not the 17 kDa frag-
ment at PND21. We also investigated Akt-1, Akt-2, Akt-3,
cleaved caspase-9, p-Bad, PARP, PTEN, ER-α, ER-β, SRC-1,
SRC-2 and SRC-3 protein expressions at PND21 but
found no differences between treatment groups at this age
(data not shown).
Cellular proliferation and apoptosis in mammary glands
of PND50 rats
Because Sprague Dawley rats are most susceptible to
chemically-induced mammary cancer at PND50 [14], we
also investigated cell proliferation and apoptosis at that
age. Prepubertal BPA treatment significantly increased
cell proliferation in mammary gland TEBs as comparedto controls (p < 0.01) (Figure 3A). On the other hand,
combinational BPA + Gen treatment significantly re-
duced cell proliferation when compared to BPA only
treatment (p < 0.001). In regard to apoptosis, genistein
treatment alone significantly increased cell apoptosis in the
mammary glands of PND50 rats (p < 0.01) (Figure 3B).
While prepubertal BPA only treatment had no significant
effect on apoptosis in the mammary gland TEBs of PND50
rats, combinational BPA +Gen treatment significantly in-
creased the index of apoptosis when compared to controls
(p < 0.01) and BPA only (p < 0.001) treated rats.
When proliferation and apoptosis were taken together as
an indicator of cellular turnover in mammary TEBs [12],
prepubertal BPA treatment alone significantly increased
cellular proliferation-to-apoptosis ratio compared with con-
trol treatment (p < 0.01) (Figure 3C). However, genistein ex-
posure alone significantly decreased the cell proliferation to
apoptosis ratio (p < 0.01). BPA +Gen combinational expos-
ure also significantly decreased the cell proliferation to
apoptosis ratio when compared with control (p < 0.01) and
BPA treatment alone (p < 0.001), similar to the effects of ge-
nistein only treatment (Figure 3C).
Protein expression in mammary glands of PND50 rats
Because of the statistically significant alterations in cell
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Figure 1 Cell proliferation and apoptosis in PND21 rats. Cell proliferation (A), apoptosis (B), and cell proliferation-to-apoptosis ratio (C) in
mammary gland TEB epithelial cells of PND21 rats exposed prepubertally via lactating dams treated with SO (Control), or BPA, or genistein or BPA
plus genistein (n = 6 rats/treatment) from PND2 through PND20. Values represent mean ± SEM. *p≤ 0.01 compared with controls; **p≤ 0.001
compared with BPA.
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susceptible for mammary cancer [14], we measured the
expression of several proteins commonly linked to cell
cycle and apoptosis at PND50. In mammary glands of
rats exposed prepubertally to BPA, we found that cleavedcaspase-3, cleaved PARP and p21 were significantly
down-regulated, while p-Bad was significantly increased
compared to control animals (no effect on cleaved
caspase-9) (Figure 4). On the other hand, prepubertal












































Figure 2 Protein expressions in PND21 rats. Western blot analysis of cleaved Caspase-3, p21 and p-Akt from mammary gland extracts of
PND21 rats exposed prepubertally via lactating dams treated with BPA and/or genistein, and SO. (A) Top panel depicts the Western blots of
mammary gland proteins from SO controls (lanes 1, 5, 9, 13, 17 and 21), BPA (lanes 2, 6, 10, 14, 18 and 22), genistein (lanes 3, 7, 11, 15, 19 and 23)
and BPA plus genistein (lanes 4, 8, 12, 16, 20 and 24) -treated groups with the appropriate antibodies shown on the left. For each treatment
group, n = 6. (B) Densitometric values of Western blots from PND21 rats were reported as a percentage of controls ± SEM. *p ≤ 0.05 compared
with controls; **p ≤ 0.05 compared with BPA; ***p≤ 0.05 compared with genistein. No significant difference was detected for the house keeping
protein GAPDH.
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rats (no significant effect on p-Bad and p21). Interestingly,
mammary glands of PND50 rats exposed prepubertally
to combinational BPA +Gen had increased protein ex-
pressions of cleaved caspase-3, cleaved caspase-9, cleaved
PARP and p21 compared to BPA only exposed rats.
Cleaved caspase-9 and cleaved PARP were also up-
regulated in animals exposed to combinational BPA +Gen
treatment compared to controls. In regard to cleaved
caspase-3, the 17 kDa and 19 kDa fragments were regu-
lated similarly compared to controls. Inactive pro-PARP
protein expression was not significantly altered between
any treatment groups. Prepubertal BPA, but not genistein
only, treatment significantly increased the expression of
the Akt-1, −2, and −3 isoforms and p-Akt, and decreased
the expression of PTEN compared to controls in PND50
rats (Figure 5). On the other hand, the mammary glands of
combinational BPA +Gen treatment had significantly de-
creased Akt-1 and p-Atk protein expression compared to
BPA only treatment.
We assessed the expression of ER-α, ER-β and steroid
receptor co-regulator (SRC) proteins known to play a
role in estrogen signalling and breast cancer following
prepubertal exposure to BPA or/and genistein. No sig-
nificant differences were observed in ER-α expression.
However, BPA and combinational BPA +Gen, but not
genistein only treatment, reduced the expression of ER-β
(Figure 6).Also, we found all three members of the p160 family
of SRC proteins, SRC-1, SRC-2 and SRC-3, were signifi-
cantly up-regulated in response to prepubertal exposure
to BPA, but down-regulated from prepubertal genistein
exposure when compared with controls. Furthermore,
the combinational exposure of BPA + Gen significantly
decreased the SRC proteins when compared with BPA
alone.
Discussion
Cell turnover is a key process involved in mammary
gland development and the pathogenesis of tumor for-
mation; hence we investigated if early prepubertal expos-
ure to BPA and genistein treatment, alone and in
combination, exerted effects on cell proliferation and
apoptosis. At PND21, rats prepubertally exposed to ge-
nistein only exhibited a 50% increase in cell proliferation
in mammary TEBs (p < 0.01), a slight but not significant
decrease in apoptosis, and a significant increase in cell
turnover (2.6-fold). These effects are consistent with pre-
vious reports of prepubertal genistein treatment inducing
rapid mammary gland growth that enhanced mammary
gland maturation and cell differentiation (at PND50) and
decreased susceptibility for chemically-induced mam-
mary cancer in adult rats [8-10]. On the other hand,
there was no significant change in cell proliferation or
apoptosis following prepubertal BPA only exposure at
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Figure 3 Cell proliferation and apoptosis in PND50 rats. Cell proliferation (A), apoptosis (B), and cell proliferation-to-apoptosis ratio (C) in
mammary gland TEB epithelial cells of PND50 rats exposed prepubertally via lactating dams treated with BPA and/or genistein (n = 6 rat/treatment)
from PND2 until PND20. Values represent mean ± SEM. *p≤ 0.01 compared with controls; **p≤ 0.001 compared with BPA.
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apoptosis, resulting in a 3.6-fold increase in cell turnover
at PND21. Since the results of combinational BPA +Gen
treatment are most similar to the outcomes observed for
genistein only treatment, we hypothesize that genistein isable to exert its effects on mammary gland maturation
and differentiation even in the presence of BPA. While
cell proliferation and apoptosis were measured in PND21
rats, it is important to point out that the observed effects


























































Figure 4 Protein expressions in PND50 rats. Western blot analysis of cleaved Caspase-3, cleaved Caspase-9, pro-PARP, cleaved PARP, p-Bad
and p21 protein expression in mammary glands of PND50 rats exposed prepubertally via lactating dams treated with BPA or/and genistein and
SO. (A) Top panel depicts the Western blots of mammary gland proteins from SO (lanes 1, 5, 9, 13, 17 and 21), BPA (lanes 2, 6, 10, 14, 18 and 22),
genistein (lanes 3, 7, 11, 15, 19 and 23) and BPA plus genistein (lanes 4, 8, 12, 16, 20 and 24) -treated groups with the appropriate antibodies
shown on the left. For each treatment group, n = 6. (B) Densitometric values of Western blots from PND50 rats were reported as a percentage of
the controls ± SEM: *p≤ 0.05 compared with controls; **p≤ 0.05 compared with BPA; and ***p≤ 0.01 compared with genistein. No significant
difference was detected for the house keeping protein GAPDH.
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and/or genistein on days 2–21.
Subsequently, we investigated cell proliferation and
apoptosis in PND50 rats exposed prepubertally to BPA
and genistein, alone and in combination. This is 30 days
after the last treatment, and a time point that, due to
metabolism, animals are free of circulating genistein and
BPA. Nevertheless, mammary TEBs of rats that were
exposed prepubertally to BPA alone had increased cell
proliferation and cell turnover by 40% and 99%, respect-
ively. However, prepubertal genistein only treatment sig-
nificantly increased cell apoptosis and decreased cell
turnover (55%). While BPA did not alter apoptosis and
genistein did not affect cell proliferation, both single
treatments changed the ratio of cell proliferation-to-
apoptosis. Furthermore, the combination of BPA + Gen
exposure on the ratio of cell proliferation to apoptosis
was similar to genistein only treatment (decreases), sug-
gesting that prepubertal genistein action could overcome
the action of prepubertal BPA treatment towards suscep-
tibility for carcinogenesis.
Because of the differential effects of BPA and genistein
on cell proliferation and apoptosis observed on PND50,we utilized western blot analysis to investigate proteins
and the pathways targeted by these chemicals. In the
mammary glands of rats exposed prepubertally to BPA
only, cleaved caspase-3, cleaved PARP and p21 were sig-
nificantly down-regulated while p-Bad was significantly
increased compared to control treated animals, intimat-
ing decreased apoptosis. A failure to undergo apoptosis
whereby DNA damaged cells are allowed to replicate is
widely believed to be a key event in cancer formation
and progression [15,16]. We believe the increase in
mammary cancer that occurs in rats exposed prepubertally
to BPA only and later to the DNA damaging carcinogen
DMBA at PND50 falls in this category [9,11,12].
On the other hand, prepubertal genistein only treat-
ment increased cleaved caspase-3, cleaved caspase-9 and
cleaved PARP compared to the mammary glands of
control treated rats. Therefore, differential regulation of
cleaved caspase-3 and cleaved PARP was observed in
comparing BPA and genistein treatments. The results of
increased cleaved caspase-9 and cleaved PARP in genis-
tein alone and BPA +Gen groups were consistent with
our cell apoptosis data. PARP is a well-established sub-












































Figure 5 Protein expressions in PND50 rats. Protein expressions of Akt-1, Akt-2, Akt-3, p-Akt and PTEN from mammary gland extracts of
PND50 exposed prepubertally via lactating dams treated with BPA or/and genistein, and SO. (A) Top panel depicts the Western blots of mammary
gland proteins from SO (lanes 1, 5, 9, 13, 17 and 21), BPA (lanes 2, 6, 10, 14, 18 and 22), genistein (lanes 3, 7, 11, 15, 19 and 23) and BPA
plus genistein (lanes 4, 8, 12, 16, 20 and 24) -treated groups with the appropriate antibodies shown on the left. For each treatment group,
n = 6. (B) Densitometric values of Western blots from PND50 rats were reported as a percentage of the controls ± SEM: *p≤ 0.05 compared
















































Figure 6 Protein expressions in PND50 rats. Protein expressions of ER-α, ER-β, SRC-1, SRC-2 and SRC-3 from mammary gland extracts of
50 day old rats exposed prepubertally via lactating dams treated with BPA or/and genistein, and SO. (A) Top panel depicts the Western blots of
mammary gland proteins from SO (lanes 1, 5, 9, 13, 17 and 21), BPA (lanes 2, 6, 10, 14, 18 and 22), genistein (lanes 3, 7, 11, 15, 19 and 23) and
BPA plus genistein (lanes 4, 8, 12, 16, 20 and 24) -treated groups with the appropriate antibodies shown on the left. For each treatment group,
n = 6. (B) Densitometric values of Western blots from PND50 rats were reported as a percentage of the controls ± SEM: *p≤ 0.05 compared with
controls; **p ≤ 0.05 compared with genistein; ***p≤ 0.0001 compared with BPA.
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tion of PARP cleavage has been used extensively as an
indicator of apoptosis [19].
The PI3K pathway is an intracellular signalling path-
way important in the regulation of apoptosis and cancer
development, being overactive when the tumor suppres-
sor PTEN is faulty or deficient [20]. Also, playing a role
in apoptosis are the Akt proteins, which promote growth
factor-mediated cell survival both directly and indirectly.
BAD is a pro-apoptotic protein of the Bcl-2 family. Akt
could phosphorylate BAD on Ser136, which makes Bad
dissociate from the Bcl-2/Bcl-X complex and lose the
pro-apoptotic function [21]. In regard to the action of
these proteins, we found that BPA only, but not genis-
tein only, treatment significantly increased the expres-
sion of the Akt-1, 2, and 3 isoforms, p-Bad and p-Akt,
but decreased on PTEN compared with control treat-
ment, suggesting that BPA could inhibit cell apoptosis
by regulation of PTEN, Akt pathway, and p-Bad in rat
mammary glands. On the other hand, Akt-1 and p-Akt
were significantly decreased in the mammary glands of
rats exposed to combinational BPA + Gen treatment
compared to BPA only treatment, pointing to the protect-
ive effect of genistein over BPA for apoptosis over cell
proliferation.
Steroid hormones can exert their actions by signalling
through intracellular steroid hormone receptors. Regula-
tion of steroid receptor action, including ER-α and ER-β,
is complex due to a number of co-regulators, including
steroid receptor co-activators, that can determine signal-
ling specificity and intensity, resulting in pleiotropic
biological effects [22,23]. But, it is not only steroid mole-
cules that act via these mechanisms. We have previously
reported that prepubertal BPA exposure resulted in up-
regulated SRCs1-3, without altering ER-α in the mam-
mary glands of 50 day old rats [9]. Here, we confirm
those effects on the SRCs, plus demonstrate that pre-
pubertal BPA exposure results in reduced expression of
ER-β. ERβ has been shown to inhibit breast cancer cell
growth by reducing cell proliferation and has been
termed a tumor suppressor [24-26]. Decreased ER-β has
been associated with proliferative preinvasive mammary
tumors [27]. So, the decreased expression of ER-β by
BPA suggests increased susceptibility for chemically-
induced mammary carcinogenesis in adult rats. Further-
more, increased expression of the SRCs could have a
dual effect, one to enhance ERβ action as a suppressor
of mammary cancer and the other to stimulate “normal”
levels of ER-α to enhance tumor-promoting effects. In
contrast, prepubertal genistein exposure resulted in
down-regulated expression of the SRCs, leading to the
opposite effect of BPA for carcinogenesis via SRC regula-
tion, i.e. mammary cancer prevention. Consistent with the
actions of genistein only, the SRCs were down-regulated inmammary glands of rats exposed to BPA +Gen, suggesting
that genistein may reduce the potential of BPA’s carcino-
genic effect towards mammary cancer development.
In summary, prepubertal BPA exposure had little dir-
ect effect on cell proliferation and apoptosis and altered
protein expression of only one out of 15 proteins investi-
gated at PND21. Nevertheless, in mature rats (30 days
later) cell proliferation and the ratio of cell proliferation
to apoptosis were significantly increased. Associated
with this at PND50 are differential expressions of 15
proteins whose alterations are consistent with increased
cell proliferation and reduced apoptosis. These data
are supportive of prior reports of rats exposed in a
similar manner to BPA prepubertally and at PND50 to
DMBA developing more mammary tumors [11,12]. We
hypothesize that DNA damaged cells from DMBA expos-
ure at PND50 that did not undergo apoptosis were
allowed to undergo long-term rapid cell proliferation to
promote mammary tumor development. Our collabora-
tive epigenetic studies have shown that mammary epithe-
lial cells from PND50 rats exposed prepubertally to BPA
revealed concurrent repression in 10 genes homologous
to the 16p11.2 loci [28]. These findings suggest that this
conserved cluster is susceptible to BPA-mediated repres-
sion in rat mammary epithelial cells and may lead to per-
manent silencing of the 16p11.2 loci, which in turn can
effect cell cycle regulation. Also, there were another 75
rat genes found to be down-regulated.
Interestingly enough, the mechanism for genistein che-
moprevention is linked to increased cell proliferation
that takes place prepubertally. As evident here, pre-
pubertal genistein exposure results in increased cell
proliferation in epithelial cells of mammary TEBs in pre-
pubertal rats. This is correlated with increased mam-
mary gland maturation and differentiation of TEBs to
lobules [8,10]. While TEBs are the terminal ductal struc-
tures most susceptible to carcinogenesis in the rat mam-
mary gland, lobules are the terminal ductal structures
least susceptible to carcinogenesis [13]. Furthermore,
prepubertal genistein exposure results in increased apop-
tosis at PND50, which could reduce the number of DNA
damaged cells.
Combinational exposures are considered by many to
be rather complex to be studied, especially in vivo. For
this reason, we selected two chemicals whose properties
we have previously studied and have shown to have op-
posing outcomes as detailed above. While genistein has
been shown to elicit estrogen-like properties, including
stimulating cell proliferation at PND21 and promoting
mammary gland maturation and cell differentiation, its
toxicological properties are questionable or minimal, es-
pecially when administered orally. Several laboratory and
epidemiological studies have demonstrated genistein and
its natural and most abundant source, soy, to suppress
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combinational BPA +Gen exposure, via the mothers’
milk, from PND2-21 resulted in increased cell prolifera-
tion and decreased apoptosis when investigated at PND21.
Furthermore, three proteins presumed to be associated
with these actions were down-regulated at PND21. At
PND50, we found that combinational BPA + Gen ex-
posure resulted in significantly decreased cell prolifera-
tion and increased apoptosis. These results were very
similar to the actions of prepubertal genistein only ex-
posure. Also, nine proteins associated with cell prolif-
eration and apoptosis were differentially regulated in a
manner consistent with suppressing cell proliferation
and increased potential for apoptosis at PND50. We
interpreted this to mean that genistein could protect
against BPA predisposition for mammary carcinogenesis.
Our data strongly suggest that the mechanism behind
these cellular responses are centred on differential protein
expressions of caspases, PARP, Bad, p21, Akts, PTEN,
ER-β and SRCs 1–3 in the rat mammary gland. Studies are
under way to determine if these cellular actions supported
by appropriate changes in long-term protein expressions
can be explained by epigenetic mechanisms and translated
into genistein suppressing BPA predisposition for mam-
mary cancer.
Conclusions
Genistein administered to rats during the prepubertal
period stimulates mammary cell proliferation at PND21,
but not at PND50, while apoptosis is increased at the
latter age. The increase in cell proliferation during early
postnatal mammary gland development has previously
been shown to promote differentiation of the mammary
terminal ductal structures and protect against chemically-
induced cancer in rats [8,10]. Of added importance is that
increased rate of apoptosis could also contribute to che-
moprevention by killing DNA damaged cells. On the
other hand, prepubertal BPA exposure increased cell
proliferation in mammary glands of PND50 rats, events
that have previously been associated with BPA predispos-
ing for chemically-induced mammary cancer at day 50
[11]. Importantly, combinational prepubertal exposure to
BPA + Gen resulted in increased cell proliferation in
PND21 rats, and decreased cell proliferation and in-
creased apoptosis in PND50 rats. The altered mechanisms
behind these cellular responses can be explained on the
basis of differential protein expressions in the rat mam-
mary gland. It appears that early exposure to genistein can
program for a “biochemical blueprint” in mammary ter-
minal ductal structures that can suppress mammary cancer
susceptibility [8-10,30].
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